ZTS
What one share of Zoetis holds
Pharmaceutical Preparations
Zoetis Inc. is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health.
Zoetis’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $22.12 |
|---|---|
| Profit | $6.12 |
| Capex (buildings and equipment) | $1.22 |
| Free cash flow | $5.38 |
| Dividends | $2.09 |
| Cash and investments | $3.56 |
| Debt | $21.85 |
| Book value | $7.60 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $9.81 | $1.65 | $0.43 | $1.00 | $0.39 | $3.02 |
| 2017 | $10.76 | $1.75 | $0.45 | $2.28 | $0.44 | $3.64 |
| 2018 | $11.96 | $2.93 | $0.69 | $2.98 | $0.54 | $4.56 |
| 2019 | $12.99 | $3.11 | $0.95 | $2.77 | $0.69 | $5.69 |
| 2020 | $13.95 | $3.42 | $0.95 | $3.50 | $0.85 | $7.93 |
| 2021 | $16.31 | $4.27 | $1.00 | $3.64 | $1.07 | $9.61 |
| 2022 | $17.18 | $4.49 | $1.25 | $2.82 | $1.35 | $9.50 |
| 2023 | $18.48 | $5.07 | $1.58 | $3.51 | $1.56 | $10.90 |
| 2024 | $20.35 | $5.47 | $1.44 | $5.05 | $1.80 | $10.64 |
| 2025 | $21.33 | $6.02 | $1.40 | $5.14 | $2.03 | $8.04 |